venlafaxine hydrochloride has been researched along with Body Weight in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (13.64) | 18.2507 |
| 2000's | 9 (40.91) | 29.6817 |
| 2010's | 10 (45.45) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Charoenphandhu, J; Charoenphandhu, N; Krishnamra, N; Lapmanee, S; Teerapornpuntakit, J | 1 |
| Correll, CU; Fay, B; Gründer, G; Haen, E; Hiemke, C; Paulzen, M; Schoretsanitis, G; Unholzer, S | 1 |
| Alén, F; de Fonseca, FR; de Heras, RG; Gorriti, MÁ; Orio, L; Pozo, MÁ; Ramírez-López, MT | 1 |
| He, J; Hou, J; Kurihara, H; Lin, F; Tian, J; Xing, Y | 1 |
| Alves, G; Falcão, A; Llerena, A; Magalhães, P | 1 |
| Fancourt, N; Ging, JM; Nelson, TY; Sharma, R; Tantsis, EM; Tran, MM | 1 |
| Mahmood, I | 1 |
| Dong, J; Gu, JY; Li, Y; Ning, QF; Shan, XW; Wang, CH; Yang, J; Zhang, XL; Zhang, YL | 1 |
| Ara, A; Banu, N; Zafir, A | 1 |
| Du, G; Gao, X; Guo, X; Li, Z; Qin, X; Sun, H; Zhang, L; Zheng, X; Zhou, Y | 1 |
| Chen, YC; Feng, SF; Shi, TY; Tan, QR; Wang, WN | 1 |
| Brusman-Lovins, L; King, KH; Malhotra, S; McElroy, SL; Welge, JA | 1 |
| Mbaya, P | 1 |
| Haack, M; Hinze-Selch, D; Koethe, D; Kraus, T; Pollmächer, T; Schuld, A | 1 |
| Allard, P; Behnke, K; Gram, L; Hanson, M; Søgaard, J; Timdahl, K | 1 |
| Borges, KD; Cunha, GM; de Bruin, GS; de Bruin, VM; de Oliveira, RA; dos Santos-Filho, EA; Viana, GS | 1 |
| Apelqvist, G; Bengtsson, F; Kugelberg, FC; Wikell, C | 1 |
| Guelfi, JD; Guichoux, JY; Hackett, D; Magni, G; White, C | 1 |
| Altenburg, SP; da-Silva, VA; Lindsey, CJ; Malheiros, LR; Thomaz, TG | 1 |
| Connor, TJ; Kelly, JP; Leonard, BE; Nolan, Y; Shen, Y | 1 |
| Apelqvist, G; Bengtsson, F; Bergqvist, PB; Hjorth, S; Kullingsjö, J; Lundmark, J; Wikell, C | 1 |
| Dunn, AJ; Swiergiel, AH | 1 |
1 review(s) available for venlafaxine hydrochloride and Body Weight
| Article | Year |
|---|---|
Venlafaxine pharmacokinetics focused on drug metabolism and potential biomarkers.
Topics: Age Factors; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Biomarkers; Body Weight; Cyclohexanols; Cytochrome P-450 Enzyme System; Genetic Markers; Humans; Kidney Diseases; Liver Diseases; Polymorphism, Genetic; Selective Serotonin Reuptake Inhibitors; Sex Factors; Smoking; Venlafaxine Hydrochloride | 2014 |
5 trial(s) available for venlafaxine hydrochloride and Body Weight
| Article | Year |
|---|---|
Venlafaxine treatment of binge-eating disorder associated with obesity: a series of 35 patients.
Topics: Adult; Aged; Ambulatory Care; Antidepressive Agents, Second-Generation; Body Weight; Bulimia; Comorbidity; Cyclohexanols; Female; Humans; Middle Aged; Obesity; Psychiatric Status Rating Scales; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2002 |
Safety and efficacy of high dose of venlafaxine XL in treatment resistant major depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Blood Pressure; Body Weight; Cyclohexanols; Depressive Disorder; Drug Resistance; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Pulse; Social Behavior; Venlafaxine Hydrochloride | 2002 |
Body weight, the tumor necrosis factor system, and leptin production during treatment with mirtazapine or venlafaxine.
Topics: Adult; Aged; Antipsychotic Agents; Body Mass Index; Body Weight; Cross-Over Studies; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Leptin; Longitudinal Studies; Male; Mianserin; Middle Aged; Mirtazapine; Tumor Necrosis Factor-alpha; Venlafaxine Hydrochloride | 2002 |
Efficacy and tolerability of venlafaxine in geriatric outpatients with major depression: a double-blind, randomised 6-month comparative trial with citalopram.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Antidepressive Agents, Second-Generation; Body Weight; Citalopram; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Severity of Illness Index; Venlafaxine Hydrochloride | 2004 |
Effectiveness of venlafaxine in patients hospitalized for major depression and melancholia.
Topics: Adult; Aged; Body Weight; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Hospitalization; Humans; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 1995 |
16 other study(ies) available for venlafaxine hydrochloride and Body Weight
| Article | Year |
|---|---|
Agomelatine, venlafaxine, and running exercise effectively prevent anxiety- and depression-like behaviors and memory impairment in restraint stressed rats.
Topics: Acetamides; Animals; Antidepressive Agents, Second-Generation; Body Weight; Corticosterone; Depression; Feeding Behavior; Immobilization; Male; Memory Disorders; Organ Size; Physical Conditioning, Animal; Rats; Rats, Wistar; Running; Stress, Physiological; Venlafaxine Hydrochloride | 2017 |
Sex and body weight are major determinants of venlafaxine pharmacokinetics.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Body Mass Index; Body Weight; Desvenlafaxine Succinate; Female; Humans; Male; Middle Aged; Sex Characteristics; Venlafaxine Hydrochloride; Young Adult | 2018 |
Increased alcohol consumption in rats after subchronic antidepressant treatment.
Topics: Alcohol Drinking; Alcohols; Analysis of Variance; Animals; Antidepressive Agents; Behavior, Addictive; Body Weight; Conditioning, Operant; Cyclohexanols; Disease Models, Animal; Fluoxetine; Male; Motor Activity; Rats; Rats, Wistar; Self Administration; Time Factors; Venlafaxine Hydrochloride | 2013 |
Gender differences in CMS and the effects of antidepressant venlafaxine in rats.
Topics: Anhedonia; Animals; Antidepressive Agents, Second-Generation; Body Weight; Corticosterone; Cyclohexanols; Female; Male; Motor Activity; Rats; Rats, Sprague-Dawley; Restraint, Physical; Sex Characteristics; Stress, Psychological; Tacrolimus Binding Proteins; Venlafaxine Hydrochloride | 2013 |
Failure to thrive potentially secondary to maternal venlafaxine use.
Topics: Antidepressive Agents, Second-Generation; Anxiety; Body Weight; Breast Feeding; Depression; Failure to Thrive; Female; Humans; Infant, Newborn; Pregnancy; Venlafaxine Hydrochloride | 2016 |
Prediction of Plasma Concentration-time Profiles of Drugs in Humans from Animals Following Oral Administration: An Allometric Approach.
Topics: Administration, Oral; Animals; Body Weight; Enoxacin; Fluoroquinolones; Half-Life; Humans; Linezolid; Metabolic Clearance Rate; Models, Biological; Monosaccharides; Sildenafil Citrate; Triazoles; Venlafaxine Hydrochloride | 2016 |
Venlafaxine ameliorates the depression-like behaviors and hippocampal S100B expression in a rat depression model.
Topics: Animals; Antidepressive Agents, Second-Generation; Body Weight; Depression; Disease Models, Animal; Gene Expression Regulation; Hippocampus; Male; Random Allocation; Rats; Rats, Sprague-Dawley; S100 Calcium Binding Protein beta Subunit; Stress, Psychological; Venlafaxine Hydrochloride | 2016 |
Invivo antioxidant status: a putative target of antidepressant action.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antioxidants; Body Weight; Cyclohexanols; Depressive Disorder; Fluvoxamine; Food Preferences; Imipramine; Lipid Peroxidation; Protein Carbonylation; Rats; Restraint, Physical; Stress, Psychological; Swimming; Taste; Venlafaxine Hydrochloride | 2009 |
Metabonomic study on chronic unpredictable mild stress and intervention effects of Xiaoyaosan in rats using gas chromatography coupled with mass spectrometry.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Biomarkers; Body Weight; Chronic Disease; Cyclohexanols; Depression; Disease Models, Animal; Drugs, Chinese Herbal; Food Preferences; Gas Chromatography-Mass Spectrometry; Male; Metabolomics; Motor Activity; Principal Component Analysis; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Stress, Psychological; Venlafaxine Hydrochloride | 2011 |
Long-lasting effects of chronic rTMS to treat chronic rodent model of depression.
Topics: Adrenocorticotropic Hormone; Anhedonia; Animals; Antidepressive Agents, Second-Generation; Antimetabolites; Blotting, Western; Body Weight; Brain; Brain-Derived Neurotrophic Factor; Bromodeoxyuridine; Cyclohexanols; Depression; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique; Food Preferences; Hydrocortisone; Male; MAP Kinase Signaling System; Motor Activity; Neurogenesis; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Stress, Psychological; Swimming; Transcranial Magnetic Stimulation; Venlafaxine Hydrochloride | 2012 |
The effect of venlafaxine on behaviour, body weight and striatal monoamine levels on sleep-deprived female rats.
Topics: Animals; Body Weight; Corpus Striatum; Cyclohexanols; Female; Immobilization; Maze Learning; Memory; Motor Activity; Rats; Rats, Wistar; Sleep Deprivation; Venlafaxine Hydrochloride | 2004 |
Open-field behavioural alterations in liver-impaired and sham-operated rats after acute exposure to the antidepressant venlafaxine.
Topics: Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Body Weight; Brain; Cyclohexanols; Liver; Locomotion; Male; Organ Size; Portacaval Shunt, Surgical; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2005 |
Postnatal development of rats exposed to fluoxetine or venlafaxine during the third week of pregnancy.
Topics: Animals; Animals, Newborn; Antidepressive Agents, Second-Generation; Birth Weight; Body Weight; Cyclohexanols; Female; Fluoxetine; Growth; Male; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Venlafaxine Hydrochloride; Weight Gain | 1999 |
Differential effect of chronic antidepressant treatments on lipopolysaccharide-induced depressive-like behavioural symptoms in the rat.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Behavior, Animal; Body Weight; Cyclohexanols; Desipramine; Drinking Behavior; Eating; Endotoxins; Escherichia coli; Interleukin-10; Lipopolysaccharides; Male; Motor Activity; Paroxetine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Tumor Necrosis Factor-alpha; Venlafaxine Hydrochloride | 1999 |
Sustained administration of the antidepressant venlafaxine in rats: pharmacokinetic and pharmacodynamic findings.
Topics: Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Biogenic Monoamines; Body Weight; Cyclohexanols; Male; Microdialysis; Rats; Rats, Sprague-Dawley; Tissue Distribution; Venlafaxine Hydrochloride | 2001 |
The reductions in sweetened milk intake induced by interleukin-1 and endotoxin are not prevented by chronic antidepressant treatment.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Appetite; Body Weight; Brain; Cyclohexanols; Depression; Dose-Response Relationship, Drug; Drug Administration Schedule; Eating; Imipramine; Interleukin-1; Lipopolysaccharides; Male; Mice; Milk; Neuroimmunomodulation; Norepinephrine; Selective Serotonin Reuptake Inhibitors; Serotonin; Venlafaxine Hydrochloride | 2001 |